Literature DB >> 16713277

Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.

Ali S Meigooni1, Sharifeh A Dini, Shahid B Awan, Kai Dou, Rafiq A Koona.   

Abstract

ADVANTAGE Pd-103 brachytherapy source has been recently introduced by IsoAid for prostate permanent implants. Dosimetric characteristics (Dose rate constant, radial dose function, 2D-, and 1D-anisotropy functions) of this source model have been determined using both theoretical and experimental methods, following the updated TG-43U1 protocol. Derivation of the dose rate constant was based on recent NIST WAFAC calibration performed in accordance with the 1999 Standards. Measurements were performed in Solid Water using LiF TLD chips and the theoretical calculations were performed in Solid Water and liquid water phantom materials using PTRAN Monte Carlo code. The results of the Monte Carlo simulation have shown a dose rate constant of 0.69 cGyh(-1) U(-1) in liquid water and 0.67 cGyh(-1) U(-1) in Solid Water medium. The measured dose rate constant in Solid Water was found to be 0.68+/-8% cGyh(-1) U(-1), which is in a good agreement (within +/-5%) to the Monte Carlo simulated data. The 2D- and 1D-anisotropy functions of the ADVANTAGE Pd-103 source were calculated for radial distances ranging from 0.5 to 5.0 cm. Radial dose function was determined for radial distances ranging from 0.2 to 8.0 cm using line source approximation. All these calculations are based on L(eff) equal to 3.61 cm, calculated following TG-43U1 recommendations. The tabulated data for 2D-anisotropy function, 1D-anisotropy function, dose rate constant and radial dose function have been produced for clinical application of this source model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713277     DOI: 10.1016/j.apradiso.2006.03.015

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.

Authors:  Zhe Jay Chen; Paul Bongiorni; Ravinder Nath
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

2.  Clinical application and validation of an iterative forward projection matching algorithm for permanent brachytherapy seed localization from conebeam-CT x-ray projections.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

3.  Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.

Authors:  Keith T Sowards
Journal:  J Appl Clin Med Phys       Date:  2007-03-20       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.